MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Neural correlates of visual cues for gait impairment in Parkinson’s disease: a preliminary analysis

    S. Stuart, J. Wagner, S. Makeig, M. Mancini (Portland, OR, USA)

    Objective: To examine the neural correlates of walking with visual cues in Parkinson’s disease (PD). Background: Gait impairment is central to PD with links to…
  • 2019 International Congress

    Distributed Global Functional Connectivity Networks Predict Responsiveness to L-DOPA and Subthalamic Deep Brain Stimulation

    C. Wu, T. Foltynie, P. Limousin, L. Zrinzo, H. Akram (Philadelphia, PA, USA)

    Objective: To investigate global resting-state functional connectivity (rsFC) patterns associated with response to L-DOPA and to subthalamic nucleus (STN) deep brain stimulation (DBS) in patients…
  • 2019 International Congress

    Effect of Subthalamic Deep Brain Stimulation (DBS) on Impulsive Control Disorders (ICD) and Dopamine Dysregulation Syndrome (DDS) – A Randomized Controlled Trial Evaluating Deep Brain Stimulation Using a New Multiple Source, Constant-Current Rechargeable System for Management of Symptoms of Parkinson’s Disease (INTREPID)

    M. Okun, R. Jain, L. Chen, I. Study Group, A. Tröster (Gainesville, FL, USA)

    Objective: To evaluate impulse control in participating subjects of the INTREPID randomized controlled trial (RCT). Background: Parkinson’s disease (PD) patients undergoing treatment with either medications…
  • 2019 International Congress

    Singing – tune into self-regulation: A holistic system perspective

    E. Wünnenberg, M. Jungen (Frankfurt Am Main, Germany)

    Objective: The aim of the single case experimental study [1] was to examine the treatment of PD under a more holistic systemic perspective similar to…
  • 2019 International Congress

    Parakinesia brachialis oscitans due to an acute medial cerebral artery stroke

    V. Gadelha, F. Germiniani, M. Lange, F. Nascimento, F. Zorzetto, P. Dos Santos, H. Teive (Curitiba, Brazil)

    Objective: To report the case of a patient with a medial cerebral artery acute stroke who developed parakinesia brachialis oscitans after thrombolysis. Background: Although rare, …
  • 2019 International Congress

    Predicting the efficacy of STN-DBS in patients with different Parkinson’s disease motor subtypes by preoperative total and partial levodopa response

    GH. Lu, ZX. Yin, YW. Jin (Nanchang, China)

    Objective: To better investigate the value of the challenge test by introducing total and partial LR, and explain the clinical significance of 30% LR through…
  • 2019 International Congress

    Kinetic Sensors for Ambulatory Gait and Balance Evaluation in Parkinson’s Disease

    K. Sharma, A. Cucca, R. Sills, J. Jung, A. Feigin, M. Biagioni (New York, NY, USA)

    Objective: To explore the applicability of an ambulatory inertial sensor (G-walk) to characterize gait function during the Timed Up and Go (TUG) Test. Background: In…
  • 2019 International Congress

    The Huntington’s Disease-Behavioral Questionnaire (HD-BQ): A New Screening Tool for Behavioral Disturbances in HD

    J. Corey-Bloom, S. Aboufadel, I. Beltran-Najera, C. Snell, M. Williams, P. Gilbert (La Jolla, CA, USA)

    Objective: To examine the usefulness of a new behavioral questionnaire for patients with, and at risk for, Huntington’s disease (HD). Background: Behavioral changes, including apathy,…
  • 2019 International Congress

    Exploring the effects of intrastriatal AAV5-miHTT therapy on MRS signal and mutant huntingtin levels in the Q175FDN mouse model of HD

    B. Leavitt, A. Vallès, A. Stam, C. Brouwers, V. Fodale, A. Bresciani, A. Hill, A. Yung, B. Russell-Schulz, P. Kozlowski, A. Mackay, D. Ma, F. Beg, J. Higgins, S. van Deventer, M. Evers, P. Konstantinova (Vancouver, BC, Canada)

    Objective: To assess the effects of intrastriatal AAV5-miHTT therapy on MRS signal and mutant huntingtin levels in the Q175FDN mouse model of HD. Background: Huntingtin…
  • 2019 International Congress

    Brain MRI Volume Changes after 12 months laquinimod treatment of Huntington disease (LEGATO-HD)

    R. Reilmann, M. Gordon, A. Feigin, K. Anderson, S. Tabrizi, B. Leavitt, J. Stout, P. Piccini, N. Hobbs, R. Manber, B. Borowsky, G. Rynkowski, R. Volkinshtein, J. Savola, M. Hayden (Victoria, Australia)

    Objective: To explore the effect of laquinimod on brain volume in patients with Huntington Disease (HD). Background: Volume loss in caudate and other brain regions…
  • « Previous Page
  • 1
  • …
  • 201
  • 202
  • 203
  • 204
  • 205
  • …
  • 217
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley